Effects of Switching to Netarsudil/Latanoprost Fixed Dose Combination from Various Latanoprost Regimens: The Phase 4 MORE Study
Jason Bacharach,1 Ehsan Sadri,2 Gagan Sawhney,3 Casey Kopczynski,4 Mohinder M Merchea4 1North Bay Eye Associates, Inc, Petaluma, CA, USA; 2Visionary Eye Institute, Newport Beach, CA, USA; 3Georgia Eye Partners, Atlanta, GA, USA; 4Alcon, Inc, Fort Worth, TX, USACorrespondence: Jason Bacharach, North...
Saved in:
Main Authors: | Bacharach J, Sadri E, Sawhney G, Kopczynski C, Merchea MM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-01-01
|
Series: | Clinical Ophthalmology |
Subjects: | |
Online Access: | https://www.dovepress.com/effects-of-switching-to-netarsudillatanoprost-fixed-dose-combination-f-peer-reviewed-fulltext-article-OPTH |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of a conjunctival contact–type drug delivery device for latanoprost using hyaluronic acid
by: Soomin Lee, et al.
Published: (2025-12-01) -
Outcomes of the Paul Glaucoma Implant in Refractory Secondary Glaucoma
by: Khodeiry MM, et al.
Published: (2025-01-01) -
Bimatoprost Intracameral Implant (Durysta®): A New Era in Glaucoma Management Through Sustained-Release Innovation
by: Vagiakis I, et al.
Published: (2025-01-01) -
Drug consumption and treatment costs of the glaucoma therapy in the Republic of Serbia
by: Ćoškov Aleksandra D., et al.
Published: (2024-01-01) -
Effects of multiples hormones on intraocular pressure: A narrative review
by: Ameenah A. Alkhaldi, et al.
Published: (2025-01-01)